Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer (original) (raw)
Andry G et al. (1989) Relation between estrogen receptor concentration and clinical and histological factors: their relative prognostic importance after radical mastectomy for primary breast cancer. Eur J Cancer Clin Oncol25: 319–329 ArticleCAS Google Scholar
Hess KR et al. (2003) Estrogen receptors and distinct patterns of breast cancer relapse. Breast Cancer Res Treat78: 105–118 ArticleCAS Google Scholar
Yasui Y and Potter JD (1999) The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control10: 431–437 ArticleCAS Google Scholar
Anderson WF et al. (2001) Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. J Clin Oncol19: 18–27 ArticleCAS Google Scholar
Li CI et al. (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev11: 601–607 PubMed Google Scholar
Chlebowski RT et al. (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst97: 439–448 Article Google Scholar
Fan C et al. (2006) Concordance among gene-expression-based predictors for breast cancer. N Engl J Med355: 560–569 ArticleCAS Google Scholar
Gruvberger S et al. (2001) Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res61: 5979–5984 CASPubMed Google Scholar
Sotiriou C et al. (2003) Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA100: 10393–10398 ArticleCAS Google Scholar
Perou CM et al. (2000) Molecular portraits of human breast tumours. Nature406: 747–752 ArticleCAS Google Scholar
Weigelt B et al. (2003) Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA100: 15901–15905 ArticleCAS Google Scholar
Cooper JA et al. (1989) Risk factors for breast cancer by oestrogen receptor status: a population-based case–control study. Br J Cancer59: 119–125 ArticleCAS Google Scholar
Nasca PC et al. (1994) Alcohol consumption and breast cancer: estrogen receptor status and histology. Am J Epidemiol140: 980–988 ArticleCAS Google Scholar
Wohlfahrt J et al. (1999) Reproductive risk factors for breast cancer by receptor status, histology, laterality and location. Int J Cancer81: 49–55 ArticleCAS Google Scholar
Sellers TA et al. (2002) Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Cancer Epidemiol Biomarkers Prev11: 1104–1107 CASPubMed Google Scholar
Colditz GA et al. (2004) Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst96: 218–228 ArticleCAS Google Scholar
Ursin G et al. (2005) Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer93: 364–371 ArticleCAS Google Scholar
Suzuki R et al. (2005) Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study. J Natl Cancer Inst97: 1601–1608 ArticleCAS Google Scholar
Garbers V et al. (2001) Changes in self-reported family history of breast cancer with change in case–control status. Eur J Epidemiol17: 517–520 ArticleCAS Google Scholar
Skegg DC (1988) Potential for bias in case–control studies of oral contraceptives and breast cancer. Am J Epidemiol127: 205–212 ArticleCAS Google Scholar
Giovannucci E et al. (1993) A comparison of prospective and retrospective assessments of diet in the study of breast cancer. Am J Epidemiol137: 502–511 ArticleCAS Google Scholar
Chen WY et al. (2002) Use of postmenopausal hormones, alcohol, and risk for invasive breast cancer. Ann Intern Med137: 798–804 Article Google Scholar
Greendale GA et al. (1997) Can we measure prior postmenopausal estrogen/progestin use? The Postmenopausal Estrogen/Progestin Interventions Trial. The PEPI Investigators. Am J Epidemiol146: 763–770 ArticleCAS Google Scholar
Althuis MD et al. (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev13: 1558–1568 CASPubMed Google Scholar
Ma H et al. (2006) Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res8: R43 Article Google Scholar
Potter JD et al. (1995) Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev4: 319–326 CASPubMed Google Scholar
Huang WY et al. (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol151: 703–714 ArticleCAS Google Scholar
Yoo KY et al. (1997) Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case–control analysis. Am J Epidemiol146: 307–314 ArticleCAS Google Scholar
Smith-Warner SA et al. (1998) Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA279: 535–540 ArticleCAS Google Scholar
Hamajima N et al. (2002) Alcohol, tobacco and breast cancer—collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer87: 1234–1245 ArticleCAS Google Scholar
Sarkola T et al. (2001) The role of the liver in the acute effect of alcohol on androgens in women. J Clin Endocrinol Metab86: 1981–1985 ArticleCAS Google Scholar
Dorgan JF et al. (2001) Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst93: 710–715 ArticleCAS Google Scholar
Fan S et al. (2000) Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res60: 5635–5639 CASPubMed Google Scholar
Singletary KW et al. (2001) Effect of ethanol on proliferation and estrogen receptor-alpha expression in human breast cancer cells. Cancer Lett165: 131–137 ArticleCAS Google Scholar
Reichman ME et al. (1993) Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst85: 722–727 ArticleCAS Google Scholar
Onland-Moret NC et al. (2005) Alcohol and endogenous sex steroid levels in postmenopausal women: a cross-sectional study. J Clin Endocrinol Metab90: 1414–1419 ArticleCAS Google Scholar
Enger SM et al. (1999) Alcohol consumption and breast cancer oestrogen and progesterone receptor status. Br J Cancer79: 1308–1314 ArticleCAS Google Scholar
Li CI et al. (2003) The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65–79 years of age. Cancer Epidemiol Biomarkers Prev12: 1061–1066 CASPubMed Google Scholar
Cotterchio M et al. (2003) Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev12: 1053–1060 CASPubMed Google Scholar
Rusiecki JA et al. (2005) Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Cancer Detect Prev29: 419–426 ArticleCAS Google Scholar
Lower EE et al. (1999) The effect of estrogen usage on the subsequent hormone receptor status of primary breast cancer. Breast Cancer Res Treat58: 205–211 ArticleCAS Google Scholar
Gajdos C et al. (2000) Breast cancer diagnosed during hormone replacement therapy. Obstet Gynecol95: 513–518 CASPubMed Google Scholar
Chen CL et al. (2002) Hormone replacement therapy in relation to breast cancer. JAMA287: 734–741 ArticleCAS Google Scholar
Ursin G et al. (2002) Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? J Clin Oncol20: 699–706 ArticleCAS Google Scholar
Kerlikowske K et al. (2003) Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol21: 4314–4321 ArticleCAS Google Scholar
Li CI et al. (2003) Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA289: 3254–3263 ArticleCAS Google Scholar
Magnusson C et al. (1996) Prognostic characteristics in breast cancers after hormone replacement therapy. Breast Cancer Res Treat38: 325–334 ArticleCAS Google Scholar
Holli K et al. (1998) Low biologic aggressiveness in breast cancer in women using hormone replacement therapy. J Clin Oncol16: 3115–3120 ArticleCAS Google Scholar
Bilimoria MM et al. (1999) Estrogen replacement therapy and breast cancer: analysis of age of onset and tumor characteristics. Ann Surg Oncol6: 200–207 ArticleCAS Google Scholar
Fowble B et al. (1999) Postmenopausal hormone replacement therapy: effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. J Clin Oncol17: 1680–1688 ArticleCAS Google Scholar
Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet350: 1047–1059
Colditz GA et al. (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med332: 1589–1593 ArticleCAS Google Scholar
Rossouw JE et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA288: 321–333 ArticleCAS Google Scholar
Colditz GA and Rosner B (2000) Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol152: 950–964 ArticleCAS Google Scholar
Ross RK et al. (2000) Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst92: 328–332 ArticleCAS Google Scholar
Schairer C et al. (2000) Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA283: 485–491 ArticleCAS Google Scholar
Early Breast Cancer Trialists' Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet351: 1451–1467
Chlebowski RT et al. (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA289: 3243–3253 ArticleCAS Google Scholar
Judd HL et al. (1982) Origin of serum estradiol in postmenopausal women. Obstet Gynecol59: 680–686 CASPubMed Google Scholar
Eliassen AH et al. (2006) Adult weight change and risk of postmenopausal breast cancer. JAMA296: 193–201 ArticleCAS Google Scholar
Feigelson HS et al. (2004) Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev13: 220–224 Article Google Scholar
Key TJ et al. (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst95: 1218–1226 ArticleCAS Google Scholar
Lahmann PH et al. (2004) Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer111: 762–771 ArticleCAS Google Scholar
Van Den Brandt PA et al. (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol152: 514–527 ArticleCAS Google Scholar
Suzuki R et al. (2006) Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: a prospective cohort study. Int J Cancer119: 1683–1689 ArticleCAS Google Scholar
Feigelson HS et al. (2006) Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women. Cancer107: 12–21 Article Google Scholar
Gail MH et al. (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst81: 1879–1886 ArticleCAS Google Scholar
Costantino JP et al. (1999) Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst91: 1541–1548 ArticleCAS Google Scholar
Chen J et al. (2006) Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst98: 1215–1226 Article Google Scholar
Rosner B and Colditz G (1996) Nurses' Health Study: log-incidence model of breast cancer incidence. J Natl Cancer Inst88: 359–364 ArticleCAS Google Scholar
Pike MC et al. (1983) 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature303: 767–770 ArticleCAS Google Scholar
Colditz GA and Rosner BA (2006) What can be learnt from models of incidence rates? Breast Cancer Res8: 208 Article Google Scholar
Rockhill B et al. (2003) Breast cancer risk prediction with a log-incidence model: evaluation of accuracy. J Clin Epidemiol56: 856–861 Article Google Scholar
Barrett-Connor E et al. (2006) Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med355: 125–137 ArticleCAS Google Scholar
Vogel VG et al. (2006) Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA295: 2727–2741 ArticleCAS Google Scholar
Cauley JA et al. (2001) Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast Cancer Res Treat65: 125–34 ArticleCAS Google Scholar
Fisher B et al. (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst97: 1652–1662 ArticleCAS Google Scholar
Chen WY et al. (2006) Unopposed estrogen therapy and the risk of invasive breast cancer. Arch Intern Med166: 1027–1032 ArticleCAS Google Scholar